Partnership Fund for New York City Company Profile

21:50 EST 9th December 2018 | BioPortfolio

The Partnership Fund for New York City is the $115 million investment arm of the Partnership for New York City ( The Fund’s mission is to engage the City’s business leaders to identify and support promising NYC-based entrepreneurs in both the for-profit and non-profit sectors to create jobs, spur new business, and expand opportunities for New Yorkers to participate in the City’s economy. The Fund is governed by a Board of Directors co-chaired by Charles “Chip” Kaye, co-chief executive officer of Warburg Pincus, and Tarek Sherif, Chairman and CEO of Medidata. Maria Gotsch serves as President and CEO of the Fund.

News Articles [1149 Associated News Articles listed on BioPortfolio]

Flatiron Health, Quentis, Rgenix & More at New York Biotech: How to Make It Here

We’re bringing the New York biotech community together once again on Tuesday, December 18 for our latest life sciences event—New York Biotech: How to Make it Here. At Riverpark at the Alexandria C...

Huobi Derivative Market auf Konferenz in New York City ins Leben gerufen

NEW YORK, 30. November 2018 /PRNewswire/ -- Auf der Cryptofrontiers Conference in New York City wurde heute der Startschuss für den nächsten Schritt beim Handel Read more...

Magnolia Neurosciences launches with $31mm Series A round

With a $31mm Series A round, Accelerator Life Science Partners launched Magnolia Neurosciences Corp. (neuroprotective therapeutics). Participants in the financing included AbbVie Ventures, Alexandria ...

Rgenix closes $40mm Series C round

Rgenix Inc. (therapeutic antibodies for cancer) raised $40mm through its Series C round. Lepu Medical led and was joined by Oceanpine Capital, Wuxi AppTec's corporate venture fund, Novo Holdings AS, S...

Increase in fentanyl -- responsible for 44 percent of New York City overdose deaths -- has led to apprehension and caution

A new study finds that people who use drugs in New York City have adjusted their behaviors to avoid overdose.

Which New York City healthcare companies raised the most dough from investors in Q2?

A New York City Health Business Leaders report details the top 12 healthcare financings of the second quarter, including investments in organizations like RubiconMD, Kronos Bio and Thrive Global.

Target continues to expand its New York City footprint

Target plans to

Missing the forest for the trees: An unexpected picture of New York City forests

(Yale School of Forestry & Environmental Studies ) An inventory of New York City's expansive yet overlooked 'forested natural areas' reveals that, contrary to previous reports, native species still co...

PubMed Articles [945 Associated PubMed Articles listed on BioPortfolio]

Pneumonia-Associated Hospitalizations, New York City, 2001-2014.

Death certificate data indicate that the age-adjusted death rate for pneumonia and influenza is higher in New York City than in the United States. Most pneumonia and influenza deaths are attributed to...

Estimating the Risk of Exposure to Fentanyl in New York City: Testing Drug Residue in Used Syringes.

To estimate the risk of exposure to fentanyl among syringe exchange program (SEP) participants in New York City.

Temporal and spatial associations between influenza and asthma hospitalisations in New York City from 2002 to 2012: a longitudinal ecological study.

To determine whether asthma hospitalisations of children and adults in the five boroughs of New York City are correlated with influenza hospitalisations temporally and spatially.

Identifying street design elements associated with vehicle-to-pedestrian collision reduction at intersections in New York City.

We evaluated associations between the installation of eleven street design elements, between 2007 and 2015, and subsequent changes in vehicle-to-pedestrian collisions in New York City.

A Tale of Two Cities: Persistently High Homicide Rates in Baltimore City Compared to Significant Declines in New York City.

Clinical Trials [721 Associated Clinical Trials listed on BioPortfolio]

Asthma and Pest Control Study: Demonstrating Return-on-Investment for In-Home Pest Control for Children With Persistent Asthma

The New York City Department of Health and Mental Hygiene and Montefiore Medical Center, with the Fund for Public Health of New York (FPHNY), DOHMH's fiscal agent, are partnering on a stud...

PowerUp for Health: A Diabetes Prevention Program for Men

The purpose of this two-year proposal is to: 1. develop and 2. complete a pilot test of an adaptation of the evidence-based National Diabetes Prevention Program (NDPP) tai...

Translating Telephonic Diabetes Self-management Support to Primary Care Practice

The goal of this study is to evaluate the implementation and effectiveness of an intervention to improve diabetes self-management, emotional distress and metabolic control among adults wit...

Centralized Reminder Recall - Flu RCT2

This study is related to a previous study, ID: NCT02924467. There are some modifications in relation to the intervention arms as well as the use of a different cohort, t...

A Regional Partnership for New York City to Improve Child Welfare Outcomes Among Pregnant Women at Risk of Substance Misuse and Their Newborns

This study recruits pregnant women and new mothers who are at risk of substance use concerns during pregnancy or delivery. These women are followed for 6 months and randomized into two gro...

Companies [2490 Associated Companies listed on BioPortfolio]

Partnership Fund for New York City

The Partnership Fund for New York City is the $115 million investment arm of the Partnership for New York City ( The Fund’s mission is to engage the City’...

Bay City Capital

Bay City Capital LLC (Bay City Capital) was established in 1997 as an equal partnership between The Craves Group LLC and certain Pritzker family business interests for the purpose of managing investme...

New York City (NYC) Business Group

New York City (NYC) Business Group is a family-owned New York City-based insurance agency specializing in Medicare, group health plans for small to medium-size businesses and employee benefits package...

City Harvest

Now serving New York City for more than 25 years, City Harvest ( is the world's first food rescue organization, dedicated to feeding the city's hungry men, women, and children. Th...


An innovative partnership between the New York Business Group on Health, the City of New York and the health insurance industry, HealthPass provides small businesses with an array of Fortune 500-quali...

More Information about "Partnership Fund for New York City" on BioPortfolio

We have published hundreds of Partnership Fund for New York City news stories on BioPortfolio along with dozens of Partnership Fund for New York City Clinical Trials and PubMed Articles about Partnership Fund for New York City for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Partnership Fund for New York City Companies in our database. You can also find out about relevant Partnership Fund for New York City Drugs and Medications on this site too.

Quick Search


Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Corporate Database Quicklinks

Searches Linking to this Company Record